News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,714 Results
Type
Article (713)
Company Profile (19)
Press Release (11982)
Section
Business (4464)
Career Advice (15)
Deals (651)
Drug Delivery (2)
Drug Development (2328)
Employer Resources (2)
FDA (199)
Job Trends (264)
News (7184)
Policy (376)
Tag
Academia (37)
Adcomms (3)
Alliances (1200)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (5)
Approvals (199)
Artificial intelligence (2)
Bankruptcy (3)
Best Places to Work (214)
BIOSECURE Act (4)
Biotechnology (15)
Cancer (32)
Cardiovascular disease (4)
Career advice (10)
CAR-T (6)
Cell therapy (17)
Clinical research (1736)
Collaboration (12)
Compensation (5)
COVID-19 (100)
CRISPR (4)
C-suite (4)
Data (26)
Diabetes (2)
Diagnostics (28)
Earnings (1364)
Events (2326)
Executive appointments (12)
FDA (213)
Featured Employer (3)
Funding (15)
Gene editing (7)
Gene therapy (13)
GLP-1 (18)
Government (43)
Healthcare (383)
Infectious disease (101)
Inflammatory bowel disease (6)
Intellectual property (3)
Interviews (3)
IPO (354)
Job creations (61)
Job search strategy (10)
Layoffs (8)
Legal (63)
Lung cancer (3)
Lymphoma (5)
Manufacturing (7)
Medical device (63)
Medtech (63)
Mergers & acquisitions (305)
Metabolic disorders (5)
Neuroscience (14)
NextGen Class of 2024 (138)
Non-profit (19)
Northern California (56)
Obesity (3)
Parkinson's disease (2)
Patents (7)
Patient recruitment (3)
People (1630)
Phase I (780)
Phase II (854)
Phase III (510)
Pipeline (12)
Policy (6)
Postmarket research (25)
Preclinical (260)
Rare diseases (4)
Real estate (111)
Regulatory (299)
Research institute (62)
Resumes & cover letters (3)
Schizophrenia (2)
Series A (5)
Southern California (58)
Startups (103)
United States (372)
Vaccines (11)
Date
Today (4)
Last 7 days (21)
Last 30 days (98)
Last 365 days (1056)
2024 (956)
2023 (1261)
2022 (1594)
2021 (1626)
2020 (1245)
2019 (733)
2018 (541)
2017 (662)
2016 (547)
2015 (593)
2014 (398)
2013 (340)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (14)
Asia (1056)
Australia (88)
California (152)
Canada (46)
China (14)
Connecticut (6)
Europe (1239)
Florida (10)
Maryland (38)
Massachusetts (68)
Minnesota (4)
New Jersey (26)
New York (12)
North Carolina (13)
Northern California (56)
Pennsylvania (22)
South America (9)
Southern California (58)
Texas (10)
Washington State (7)
12,714 Results for "vaxil biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
August 21, 2024
·
10 min read
Vaxil Provides Update on Research Activities and Management Changes
VAXIL BIO LTD., an innovative immunotherapy biotech company specializing in cancer and infectious diseases announces the follow update on its research activities and changes in senior management.
August 2, 2023
·
5 min read
Press Releases
Calidi Biotherapeutics Announces Proposed Public Offering
November 14, 2024
·
4 min read
Press Releases
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference 2024
November 12, 2024
·
3 min read
Press Releases
FORE Biotherapeutics to Participate in Upcoming November Conferences
November 7, 2024
·
1 min read
Press Releases
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
SAb Biotherapeutics Rebrands as SAB BIO
SAB Biotherapeutics today announced its new name, SAB BIO, and visual identity to more closely align with its mission to treat and prevent immune and autoimmune disorders with the use of its unique immunotherapy platform.
June 20, 2024
·
5 min read
Press Releases
Oxford BioTherapeutics to Present at World ADC Conference 2024
October 31, 2024
·
3 min read
Press Releases
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
October 29, 2024
·
2 min read
Press Releases
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 13, 2024
·
8 min read
1 of 1,272
Next
